J Korean Med Assoc.  2004 Jul;47(7):604-610. 10.5124/jkma.2004.47.7.604.

Epidermiological and Clinical Features of Occlusive Cerebrovascular Disease

• Lee BC
• Kim JH

• KMID: 2183478
• DOI: http://doi.org/10.5124/jkma.2004.47.7.604

Abstract

Stroke is one of the leading causes of deaths in Korea. According to the report from Korean National Statistical Office, the mortality rate of stroke was 77.2/100,000 persons in 2002. In the past, hemorrhagic stroke was more prevalent than ischemic stroke in Korea. However, the ratio of hemorrhagic to ischemic stroke has been reversed since late-1980s. This trend might be due to the westernization of lifestyle as well as better control of stroke risk factors such as hypertension and diabetes. Of ischemic stroke, the incidence of cardioembolism is relatively low in Korea compared with in Western countries, especially in posterior circulation disorders. This observation reflects the epidemiologic characteristic of stroke in Korea where the prevalence of cardiac diseases is relatively low. The case fatality rate from one of the largest hospital-based stroke registries was 7.7% within 30 days after the onset of acute ischemic stroke, which is similar to those from other series in western countries with advanced medical care systems. However, the delay of hospital visit after the onset of stroke and the lower compliance for secondary prevention remain obstacles in managing stroke patients in Korea.

Keyword

Ischemic stroke; Epidemiology; Case fatality rate; Korea

MeSH Terms

Cause of Death
Compliance
Epidemiology
Heart Diseases
Humans
Hypertension
Incidence
Korea
Life Style
Mortality
Prevalence
Registries
Risk Factors
Secondary Prevention
Stroke

Figure

• 

  Figure 1

• 

  Figure 2

Reference

2. Klag MJ, Whelton PK, Seider AJ. Decline in US stroke mortality : Demographic trends and antihypertensive treatment. Stroke. 1989. 20:14–21.

3. Cooper R, Sempos C, Hsieh S-C, Kovar MG. Slowdown in the decline of stroke mortality in the United States, 1978-1986. Stroke. 1990. 21:1274–1279.

4. Gillum RF. Cerebrovascular disease morbidity in the United States, 1970-1983:Age, sex, region, and vascular surgery. Stroke. 1986. 17:656–651.

5. Wolf PA, D'agostino RB. Epidemiology of stroke. Stroke. Pathophysiology, diagnosis, and management. 1998. 3rd ed. New York: Churchill Livingstone;3–28.

12. Lee BI, Nam HS, Heo JH, Kim DI. The Yonsei Stroke Team. Yonsei Stroke Registry. Cerebrovasc dis. 2001. 12:145–151.

15. McGovern PG, Burke GL, Sprafka JM. Trends in morbidity, mortality and risk factor levels for stroke from 1960 through 1990 : The Minnesota Heart Survey. JAMA. 1992. 268:753–759.

16. Collins R, MacMahon S. Blood pressure, antihypertensive treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994. 50:272–298.

18. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981. 12:474–477.

19. Ahmed OI, Orchard JT, Sharma R, Mitchell H, Talbo E. Declining mortality from stroke in Allegheny Country, Pennsylvania : Trends in case fatality and severity of disease, 1971-1980. Stroke. 1988. 19:181–184.

20. Ueda K, Hasuo Y, Kiyohara Y. Intracerebral hemorrhage in a Japanese community, Hisayama : Incidence, changing pattern during longterm follow-up, and related factors. Stroke. 1988. 19:48–52.

21. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995. 333:1581–1587.

25. Kim JS, Yoon SS. Perspectives of Stroke in Persons Living in Seoul, South Korea, A survey of 1,000 Subjects. Stroke. 1997. 28:1165–1169.